Preferred test to follow-up presumptive results. For general screening, Phencyclidine, Urine Screen with Reflex to Quantitation (2012265) is preferred.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Transport 1 mL urine. (Min: 0.5 mL)
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years (Avoid repeated freeze/thaw cycles)
Effective August 17, 2015
|Drugs Covered||Cutoff Concentrations|
Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry.
Positive cutoff: 10 ng/mL.
For medical purposes only; not valid for forensic use.
The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
83992 (Alt code: G0480)
|Component Test Code*||Component Chart Name||LOINC|
|2010463||Phencyclidine (PCP), Urn, Quant||3937-0|
- Pain Management, Phencyclidine, Quantitative, with medMATCH, Urine
- Pain Management, Phencyclidine, with Confirmation with medMATCH, Urine